monogramorthopedics.com (MGRM): Rentabilitas operasi

Monogram Technologies (MGRM) - logo korporat

Monogram Technologies (MGRM) serves as a defensive asset, as demand for medtech remains independent of macroeconomic conditions. FDA approval and the launch of robotic orthopedic systems will drive revenue growth. The recorded operating margin confirms this trend, with the metric fixed at 0.00. Navigation patents and the requirement for physician training on the platform create a high barrier to entry.

MGRM - Rasio bathi operasi Monogram Orthopedics ing rentang 21.02.2024 - 18.10.2025

Rincian analitis perusahaan Monogram Technologies

- rega saham lan konsensus proyeksi valuasi:
Analisis fundamental perusahaan:MGRM, Monogram Technologies
Barang utama Monogram Technologies

This metric focuses on operational efficiency, excluding the impact of credit policy and tax regimes. It measures the share of profit from core processes relative to total revenue. For Monogram Technologies (MGRM), this indicator depends on the margins of robotic systems and 3D implants sales. Analyzing the operating margin allows for an assessment of the business's ability to pass costs onto medical centers. The operating margin trend reveals the actual resilience of sales.

Perusahaan pesaing

ISRG (intuitive.com) - Margin operasi|Rentabilitas dodolan miturut bathi operasi DHR (Danaher Corp.)|Margin dodolan operasi BDX (Becton, Dickinson and Company)|Rasio bathi operasi STE|Rentabilitas operasi West Pharma WST|Rentabilitas kegiatan operasi Baxter (BAX)|MASI - Rentabilitas operasi|Rentabilitas kegiatan operasi Stevanato Group Corp STVN|TFX: Margin operasi|Margin dodolan operasi Merit Medical Systems|Rentabilitas operasi Envista Holdings Corp|Margin dodolan operasi ICU Medical Corp (ICUI)|Rentabilitas operasi DENTSPLY SIRONA Inc. (XRAY)|Margin dodolan operasi LeMaitre LMAT|Margin operasi ATRC (atricure.com)|Margin operasi staar.com STAA|NAGE - Rentabilitas operasi|Rentabilitas kegiatan operasi ZimVie ZIMV|ANGO: Margin operasi|Cerus Corp - Tingkat bathi operasi|Margin dodolan operasi TKNO|STSS: Tingkat bathi operasi|Margin dodolan operasi INFU (InfuSystem Holdings)|Utah Medical Products, Inc. - Rentabilitas dodolan miturut bathi operasi|Margin operasi KRMD (korumedical.com)|Rentabilitas kegiatan operasi Nyxoah, S.A. (NYXH)|MBOT - Rentabilitas operasi|PDEX (Pro-Dex, Inc.) - Rentabilitas dodolan miturut bathi operasi|ZTEK (Zentek Ltd) - Margin dodolan operasi|ELUT - Rentabilitas kegiatan operasi|MLSS (Milestone Scientific Corporation) - Margin operasi|Rentabilitas dodolan miturut bathi operasi NXGL (NEXGEL, Inc.)|Margin operasi RVP|Margin dodolan operasi Harvard Bioscience HBIO|Margin operasi FEMY (Femasys Corporation)|MHUA - Margin dodolan operasi|POAI - Rentabilitas operasi|Callan JMB (CJMB) - Margin dodolan operasi|ATRI: Margin operasi|NURO - Rentabilitas kegiatan operasi